Grail Inc GRAL eyes early 2027 FDA approval for Galleri after a favorable advisory committee vote, even as revenue growth slows and losses widen.
Why Is Grail, Inc. (GRAL) Stock Down Today?
Updated Nov 16, 2026 8:30 PM ET · 18m ago · Prev Close $115.89
Primary Move Catalyst & Conviction
70% Signal ConvictionUnusual Put buying detected
Options traders are heavily buying puts on GRAL, with 81% of volume in puts. This suggests bearish institutional positioning.
This appears to be a sector-wide move. The Medical Laboratories sector is down 4.2% on average.
Market & Sector Relative Strength
GRAL lagging the S&P 500 by -6.97%Options Flow & Execution Desk
Neutral Flow · P/C 0.86Unlock 1 Strike-Verified Options Setup for GRAL
Our options desk modeled Bear Put Debit Spread structures for the Dec 18 expiration cycle, plus live unusual contract strike sweeps and full factor sub-scores.
Recent GRAL Catalyst Headlines
Verified WireGrail stock took a mighty hit Thursday after the DNA-testing outfit reported light third-quarter sales for its blood test.
Grail Gral just put fresh numbers on the table, with third quarter 2026 results showing US 37.5 million in revenue alongside a net loss of about US 103.6 million. GRAIL s stock has been on a volatile run, with a 1-day sh
Promotional pricing lifted test volume sharply, but margins fell and losses widened.
1–3 Day Expected Range & Key Level
45% Follow-ThroughWatch for breakdown below $107.00
Technical Regime (GRAL)
MIXED MA TREND1-Year Historical Move Analogs
62 EventsSessions in the past year where GRAL moved >3.0% down:
Retail & Crowd Sentiment
BullishGrail reported Q3 revenue missing estimates despite a favorable FDA vote for its cancer-detecting test, leading to a significant stock price decline.
About Grail, Inc.
Grail Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides m...
Get Instant GRAL Catalyst Alerts
Receive an email alert when GRAL triggers an unusual volume breakout, options sweep, or rating shift.
Other Liquid Stocks Moving Today
All Today's MoversGRAL Session & Catalyst FAQ
Why is GRAL stock down today?
Options traders are heavily buying puts on GRAL, with 81% of volume in puts. This suggests bearish institutional positioning.
Is GRAL stock a buy or sell right now?
Today's session carries a 70% catalyst conviction score on 0.48x relative volume (low participation). Our multi-factor model currently rates GRAL as HOLD. Review full valuation, quality, and timing signals on the GRAL Buy or Sell Decision Brief →
What is GRAL's intrinsic value and expected trading range?
At $105.60, GRAL's modeled 1-to-3 session range is $103.79 – $109.13, with a key inflection level at $101.65 (support). Compare current price against multi-year cash flow projections in the GRAL Intrinsic Value & DCF Model → and Market Cycle Phase Tracker →
What do RSI and moving averages signal for GRAL?
RSI at 37.7 reflects soft below-midline momentum. GRAL trades at $105.60 relative to its 20-day SMA ($132.32) and 50-day SMA ($121.37), reflecting a mixed moving-average structure.
Tradestie Flagship Research & Market Hubs
Live institutional catalyst tape ranking liquid gainers, losers, options sweeps, and RVOL surges.
Track spot H100/B200 compute rental rates and frontier LLM inference token economics.
Wafer yield, CoWoS packaging, and HBM bill-of-materials teardown models across AI accelerators.
Monitor engineering velocity and upstream foundry wafer demand inflections across tech leaders.
Live conviction tracking, invalidation guardrails, and thesis health checks on flagship ideas.
Backtest-validated unusual options positioning and open-interest accumulation setups.
Daily ranked quantitative leaderboard with audited forward-return track record vs S&P 500.
High-yield, quality-screened cash-secured put and put-spread income candidates.